Effects of Lactoferrin on Prevention of Acute Gastrointestinal Symptoms in Winter: A Randomized, Double-Blinded, Placebo-Controlled Trial for Staff of Kindergartens and Nursery Schools in Japan

Int J Environ Res Public Health. 2020 Dec 21;17(24):9582. doi: 10.3390/ijerph17249582.

Abstract

This study investigated the preventive effects of lactoferrin (LF) on subjective acute gastrointestinal symptoms during the winter in a randomized, double-blinded, placebo-controlled parallel-group comparative trial. The eligible subjects were healthy adults working at kindergartens and nursery schools. We randomized the subjects to the Placebo group (0 mg/day), the Low LF group (200 mg/day), and the High LF group (600 mg/day) for 12 weeks. The prevalence of acute gastrointestinal symptoms was significantly lower in the High LF (13/112 vs. 26/116; p = 0.030) and the Low LF (13/107 vs. 26/116; p = 0.040) groups than in the Placebo group. The adjusted odds ratio for the prevalence of acute gastrointestinal symptoms was 2.78 (95% CI: 1.19-6.47) in the Placebo group compared with the High LF group. LF is useful to prevent acute gastrointestinal symptoms among childcare workers, who mainly consist of women.

Keywords: diarrhea; kindergarten; lactoferrin; subjective acute gastrointestinal symptoms; winter.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Anti-Infective Agents / therapeutic use*
  • Double-Blind Method
  • Female
  • Gastrointestinal Diseases / drug therapy
  • Gastrointestinal Diseases / epidemiology
  • Gastrointestinal Diseases / prevention & control*
  • Humans
  • Japan / epidemiology
  • Lactoferrin / therapeutic use*
  • Schools, Nursery

Substances

  • Anti-Infective Agents
  • Lactoferrin